Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Guidance
Reports fourth quarter 2022 commercial revenue of $4.4 million
Related news for (RPID)
- Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.
- Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors
- 24/7 Market News Snapshot 09 May, 2025 – Rapid Micro Biosystems, Inc. Class A Common Stock (NASDAQ:RPID)
- Rapid Micro Biosystems Reports First Quarter 2025 Financial Results
- MoBot alert highlights: NASDAQ: ADTX, NASDAQ: BTAI, NASDAQ: TRNR, NASDAQ: ARBB, NASDAQ: RPID (02/28/25 07:00 AM)